Review



limk inhibitor  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Tocris limk inhibitor
    Limk Inhibitor, supplied by Tocris, used in various techniques. Bioz Stars score: 92/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/limk inhibitor/product/Tocris
    Average 92 stars, based on 3 article reviews
    limk inhibitor - by Bioz Stars, 2026-04
    92/100 stars

    Images



    Similar Products

    94
    MedChemExpress limk inhibitor bms 3
    Limk Inhibitor Bms 3, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/limk inhibitor bms 3/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    limk inhibitor bms 3 - by Bioz Stars, 2026-04
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress bms-3
    Bms 3, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bms-3/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    bms-3 - by Bioz Stars, 2026-04
    94/100 stars
      Buy from Supplier

    90
    Bristol Myers selective inhibitor of limk activity
    <t>LIMK</t> <t>activity</t> promotes VSMC migration. The activation of RhoA/ROCK by stimuli such as PDFG-BB leads to the phosphorylation of LIMK and inactivation of cofilin, thereby promoting actin polymerization. Concurrently, ROCK phosphorylates MLCP and inhibits its activity, resulting in increased phosphorylation of MLC and subsequent VSMC contraction. Activation of inflammatory cytokines such as CCR8, CKLF1, and CXCL12 also modulates cell migration via lamellipodia formation. These inflammatory processes likely promote VSMC migration in a LIMK-dependent manner. Whether inflammatory cytokines activate LIMK via Rac2 activation remains unknown. (PDFG-BB: Platelet derived growth factor BB; Arp 2/3: Actin related protein 2/3; CCR8: chemokine receptor-8; CKLF1: Chemokine-like factor 1; CXCL12: C-X-C motif chemokine 12; MLCP: Myosin light chain phosphatase).
    Selective Inhibitor Of Limk Activity, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/selective inhibitor of limk activity/product/Bristol Myers
    Average 90 stars, based on 1 article reviews
    selective inhibitor of limk activity - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    92
    Tocris limk inhibitor
    <t>LIMK</t> <t>activity</t> promotes VSMC migration. The activation of RhoA/ROCK by stimuli such as PDFG-BB leads to the phosphorylation of LIMK and inactivation of cofilin, thereby promoting actin polymerization. Concurrently, ROCK phosphorylates MLCP and inhibits its activity, resulting in increased phosphorylation of MLC and subsequent VSMC contraction. Activation of inflammatory cytokines such as CCR8, CKLF1, and CXCL12 also modulates cell migration via lamellipodia formation. These inflammatory processes likely promote VSMC migration in a LIMK-dependent manner. Whether inflammatory cytokines activate LIMK via Rac2 activation remains unknown. (PDFG-BB: Platelet derived growth factor BB; Arp 2/3: Actin related protein 2/3; CCR8: chemokine receptor-8; CKLF1: Chemokine-like factor 1; CXCL12: C-X-C motif chemokine 12; MLCP: Myosin light chain phosphatase).
    Limk Inhibitor, supplied by Tocris, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/limk inhibitor/product/Tocris
    Average 92 stars, based on 1 article reviews
    limk inhibitor - by Bioz Stars, 2026-04
    92/100 stars
      Buy from Supplier

    93
    Selleck Chemicals limk inhibitor bms 5
    <t>LIMK</t> <t>activity</t> promotes VSMC migration. The activation of RhoA/ROCK by stimuli such as PDFG-BB leads to the phosphorylation of LIMK and inactivation of cofilin, thereby promoting actin polymerization. Concurrently, ROCK phosphorylates MLCP and inhibits its activity, resulting in increased phosphorylation of MLC and subsequent VSMC contraction. Activation of inflammatory cytokines such as CCR8, CKLF1, and CXCL12 also modulates cell migration via lamellipodia formation. These inflammatory processes likely promote VSMC migration in a LIMK-dependent manner. Whether inflammatory cytokines activate LIMK via Rac2 activation remains unknown. (PDFG-BB: Platelet derived growth factor BB; Arp 2/3: Actin related protein 2/3; CCR8: chemokine receptor-8; CKLF1: Chemokine-like factor 1; CXCL12: C-X-C motif chemokine 12; MLCP: Myosin light chain phosphatase).
    Limk Inhibitor Bms 5, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/limk inhibitor bms 5/product/Selleck Chemicals
    Average 93 stars, based on 1 article reviews
    limk inhibitor bms 5 - by Bioz Stars, 2026-04
    93/100 stars
      Buy from Supplier

    90
    Cayman Chemical limk- 1/2 inhibitor bms- 5
    <t>LIMK</t> <t>activity</t> promotes VSMC migration. The activation of RhoA/ROCK by stimuli such as PDFG-BB leads to the phosphorylation of LIMK and inactivation of cofilin, thereby promoting actin polymerization. Concurrently, ROCK phosphorylates MLCP and inhibits its activity, resulting in increased phosphorylation of MLC and subsequent VSMC contraction. Activation of inflammatory cytokines such as CCR8, CKLF1, and CXCL12 also modulates cell migration via lamellipodia formation. These inflammatory processes likely promote VSMC migration in a LIMK-dependent manner. Whether inflammatory cytokines activate LIMK via Rac2 activation remains unknown. (PDFG-BB: Platelet derived growth factor BB; Arp 2/3: Actin related protein 2/3; CCR8: chemokine receptor-8; CKLF1: Chemokine-like factor 1; CXCL12: C-X-C motif chemokine 12; MLCP: Myosin light chain phosphatase).
    Limk 1/2 Inhibitor Bms 5, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/limk- 1/2 inhibitor bms- 5/product/Cayman Chemical
    Average 90 stars, based on 1 article reviews
    limk- 1/2 inhibitor bms- 5 - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Cayman Chemical limk-1/2 inhibitor bms-5
    <t>LIMK</t> <t>activity</t> promotes VSMC migration. The activation of RhoA/ROCK by stimuli such as PDFG-BB leads to the phosphorylation of LIMK and inactivation of cofilin, thereby promoting actin polymerization. Concurrently, ROCK phosphorylates MLCP and inhibits its activity, resulting in increased phosphorylation of MLC and subsequent VSMC contraction. Activation of inflammatory cytokines such as CCR8, CKLF1, and CXCL12 also modulates cell migration via lamellipodia formation. These inflammatory processes likely promote VSMC migration in a LIMK-dependent manner. Whether inflammatory cytokines activate LIMK via Rac2 activation remains unknown. (PDFG-BB: Platelet derived growth factor BB; Arp 2/3: Actin related protein 2/3; CCR8: chemokine receptor-8; CKLF1: Chemokine-like factor 1; CXCL12: C-X-C motif chemokine 12; MLCP: Myosin light chain phosphatase).
    Limk 1/2 Inhibitor Bms 5, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/limk-1/2 inhibitor bms-5/product/Cayman Chemical
    Average 90 stars, based on 1 article reviews
    limk-1/2 inhibitor bms-5 - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    Image Search Results


    LIMK activity promotes VSMC migration. The activation of RhoA/ROCK by stimuli such as PDFG-BB leads to the phosphorylation of LIMK and inactivation of cofilin, thereby promoting actin polymerization. Concurrently, ROCK phosphorylates MLCP and inhibits its activity, resulting in increased phosphorylation of MLC and subsequent VSMC contraction. Activation of inflammatory cytokines such as CCR8, CKLF1, and CXCL12 also modulates cell migration via lamellipodia formation. These inflammatory processes likely promote VSMC migration in a LIMK-dependent manner. Whether inflammatory cytokines activate LIMK via Rac2 activation remains unknown. (PDFG-BB: Platelet derived growth factor BB; Arp 2/3: Actin related protein 2/3; CCR8: chemokine receptor-8; CKLF1: Chemokine-like factor 1; CXCL12: C-X-C motif chemokine 12; MLCP: Myosin light chain phosphatase).

    Journal: Frontiers in Physiology

    Article Title: LIM kinases in cardiovascular health and disease

    doi: 10.3389/fphys.2024.1506356

    Figure Lengend Snippet: LIMK activity promotes VSMC migration. The activation of RhoA/ROCK by stimuli such as PDFG-BB leads to the phosphorylation of LIMK and inactivation of cofilin, thereby promoting actin polymerization. Concurrently, ROCK phosphorylates MLCP and inhibits its activity, resulting in increased phosphorylation of MLC and subsequent VSMC contraction. Activation of inflammatory cytokines such as CCR8, CKLF1, and CXCL12 also modulates cell migration via lamellipodia formation. These inflammatory processes likely promote VSMC migration in a LIMK-dependent manner. Whether inflammatory cytokines activate LIMK via Rac2 activation remains unknown. (PDFG-BB: Platelet derived growth factor BB; Arp 2/3: Actin related protein 2/3; CCR8: chemokine receptor-8; CKLF1: Chemokine-like factor 1; CXCL12: C-X-C motif chemokine 12; MLCP: Myosin light chain phosphatase).

    Article Snippet: Since the first report on the development of a selective inhibitor of LIMK activity by Bristol-Myers-Squibb in 2006, only one such molecule has reached clinical trials for treating glaucoma ( ).

    Techniques: Activity Assay, Migration, Activation Assay, Phospho-proteomics, Derivative Assay

    Representative studies on the role of  LIMK  in cardiovascular diseases.

    Journal: Frontiers in Physiology

    Article Title: LIM kinases in cardiovascular health and disease

    doi: 10.3389/fphys.2024.1506356

    Figure Lengend Snippet: Representative studies on the role of LIMK in cardiovascular diseases.

    Article Snippet: Since the first report on the development of a selective inhibitor of LIMK activity by Bristol-Myers-Squibb in 2006, only one such molecule has reached clinical trials for treating glaucoma ( ).

    Techniques: Migration